enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Fibrogen Inc (FGEN) SVP, Finance and CFO Pat Cotroneo Sold ...

    www.aol.com/news/fibrogen-inc-fgen-svp-finance...

    SVP, Finance and CFO of Fibrogen Inc (30-Year Financial, Insider Trades) Pat Cotroneo (insider trades) sold 15,004 shares of FGEN on 09/03/2020 at an average price of $50.91 a share.

  3. FibroGen (FGEN) Q3 Earnings and Revenues Surpass Estimates - AOL

    www.aol.com/news/fibrogen-fgen-q3-earnings...

    FibroGen (FGEN) delivered earnings and revenue surprises of 500.00% and 15.25%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  4. FibroGen (FGEN) Reports Q4 Loss, Lags Revenue Estimates - AOL

    www.aol.com/news/fibrogen-fgen-reports-q4-loss...

    FibroGen (FGEN) delivered earnings and revenue surprises of -113.24% and 62.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

  5. FibroGen Stock Gives Every Indication Of Being Possible Value ...

    www.aol.com/news/fibrogen-stock-gives-every...

    The stock of FibroGen (NAS:FGEN, 30-year Financials) is estimated to be possible value trap, according to GuruFocus Value calculation.

  6. FibroGen, Inc.'s (NASDAQ:FGEN) Intrinsic Value Is ... - AOL

    www.aol.com/news/fibrogen-inc-nasdaq-fgen...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Kadant - Wikipedia

    en.wikipedia.org/wiki/Kadant

    Kadant Inc. is a company that was established in 1991, as a partly privately owned subsidiary of Thermo Electron, and partly publicly traded company, and was fully spun out and renamed Kadant in 2001. The company supports papermaking, paper recycling, wood processing, material handling, and other processing industries. Kadant is a multi ...

  8. News Flash: 10 Analysts Think FibroGen, Inc. (NASDAQ ... - AOL

    www.aol.com/news/news-flash-10-analysts-think...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Is Fibrogen Still a Buy Following Data Analysis Faux Pas ...

    www.aol.com/news/fibrogen-still-buy-following...

    No one likes being given the wrong information. Investors reacted in dismay and sent Fibrogen (FGEN) shares deep into the red following the company's embarrassing announcement. The biotech company ...